Chronic rhinosinusitis with nasal polyps (CRSwNP) is a challenging disease process. The growth of polyp tissue blocks the sinonasal passages and leads to the development of sinusitis. Medical therapy, to include topical and systemic corticosteroids, result in improvement in these systems. However, patients with CRSwNP often require surgery to remove the polyps to improve ventilation and drainage. Despite our best surgical efforts, polyps frequently regrow with a return of symptoms. Often, these patients will require additional surgery. As such, it is important to identify modifiable factors to delay revision sinus surgery.
From April 1987 to June 2012, 299 patients were identified who had two or more sinus surgeries with findings of nasal polyps during their first and second procedures. Demographics such as gender, smoking history, and history of asthma were recorded, as was middle turbinate resection and findings of allergic mucin or tissue eosinophilia on pathology reports. Time to revision surgery was defined as the number of days between the first and second surgery. If a patient underwent more than two surgeries, the average time to recurrence was used.
There were 691 surgeries performed among the 299 patients with CRSwNP, with an average of 2.31 surgeries per patient. The mean time between sinus surgeries was 4.87 years. Multivariate analysis showed that a smoking history resulted in a significantly shorter duration of time to revision surgery, with a mean of 2.82 years in smokers and 4.31 years in non-smokers (p ϭ .022). Patients who had a middle turbinate resection at the time of surgery had a significantly longer time between revision surgery when compared to patients who did not have the middle turbinate removed (4.56 years vs. 3.93 years, p ϭ .048). Patients with a history of asthma, allergic mucin, and tissue eosinophilia did not significantly alter the time to revision surgery.
The study by Wu et al has several strong points. It is a retrospective study that attempts to look objectively at factors that slow regrowth of polyp tissue, resulting in longer durations between revision surgeries. Prophylaxis is an effective way to avoid surgery and limit spending, and this paper introduces two potential modalities to the clinician. The data is the result of a single, senior surgeon, limiting surgical technique and clinical decision-making. One weakness arose when the author was unable to measure the differences in polyp regrowth with postoperative medical treatments. Certainly, topical steroids and nasal saline rinses are an important part to curtail and prevent the regrowth of polyps in CRSwNP after surgery.
Overall, this is an excellent study that offers modifiable factors for improved symptom control in patients with CRSwNP. Wu et al demonstrate that middle turbinate resection should be carefully considered by the surgeon when performing sinus surgery in these patients. Additionally, proper smoking cessation counseling is a necessity when treating a patient with CRSwNP.
